Effect of Hyperoxia on Myocardial Oxygenation and Function in Patients With Stable Multivessel Coronary Artery Disease

Dominik P Guensch, Kady Fischer, Kyohei Yamaji, Silvia Luescher, Yasushi Ueki, Bernd Jung, Gabor Erdoes, Christoph Gräni, Hendrik von Tengg-Kobligk, Lorenz Räber, Balthasar Eberle, Dominik P Guensch, Kady Fischer, Kyohei Yamaji, Silvia Luescher, Yasushi Ueki, Bernd Jung, Gabor Erdoes, Christoph Gräni, Hendrik von Tengg-Kobligk, Lorenz Räber, Balthasar Eberle

Abstract

Background The impact of hyperoxia, that is, supraphysiological arterial partial pressure of O2, on myocardial oxygen balance and function in stable multivessel coronary artery disease (CAD) is poorly understood. In this observational study, we assessed myocardial effects of inhalational hyperoxia in patients with CAD using a comprehensive cardiovascular magnetic resonance exam. Methods and Results Twenty-five patients with stable CAD underwent a contrast-free cardiovascular magnetic resonance exam in the interval between their index coronary angiography and subsequent revascularization. The cardiovascular magnetic resonance exam involved T1 and T2 mapping for tissue characterization (fibrosis, edema) as well as function imaging, from which strain analysis was derived, and oxygenation-sensitive cardiovascular magnetic resonance imaging. The latter modalities were both acquired at room air and after breathing pure O2 by face mask at 10 L/min for 5 minutes. In 14 of the 25 CAD patients (56%), hyperoxia induced poststenotic myocardial deoxygenation with a subsequent oxygenation discordance across the myocardium. Extent of deoxygenation was correlated to degree of stenosis (r=-0.434, P=0.033). Hyperoxia-associated poststenotic deoxygenation was accompanied by ipsiregional reduction of diastolic strain rate (1.39±0.57 versus 1.18±0.65; P=0.045) and systolic radial velocity (37.40±17.22 versus 32.88±13.58; P=0.038). Increased T2, as well as lower cardiac index, and defined abnormal strain parameters on room air were predictive for hyperoxia-induced abnormalities (P<0.05). Furthermore, in patients with prolonged native T1 (>1220 ms), hyperoxia reduced ejection fraction and peak strain. Conclusions Patients with CAD and pre-existent myocardial injury who respond to hyperoxic challenge with strain abnormalities appear susceptible for hyperoxia-induced regional deoxygenation and deterioration of myocardial function. Clinical Trial Registration URL: http://www.clinicaltrials.gov. Unique identifier: NCT02233634.

Keywords: blood‐oxygen level dependence; coronary artery disease; hyperoxia; oxygen; oxygenation‐sensitive cardiovascular magnetic resonance.

Figures

Figure 1
Figure 1
Exemplary coronary artery disease patient with hyperoxia‐induced decrease of global systolic and diastolic function. This patient had a maximal left anterior descending coronary artery (LAD) diameter stenosis of 61% (A) at CMR (cardiovascular magnetic resonance). The left circumflex coronary artery with a left‐dominant pattern was reperfused (stented) after presenting with a non–ST‐segment–elevation myocardial infarction 44 days before the staged percutaneous coronary intervention and CMR. Left ventricular ejection fraction decreased below 50% and cardiac index below 2.5 L/min/m2 during hyperoxia (B). The T1 mapping image (C, top) shows myocardial injury in the subendocardial layer of the anteroseptal segment (orange). This matches a hyperoxia‐induced oxygenation deficit (blue; C, bottom) observed in the LAD territory. This further corresponded to a regional decrease in early diastolic circumferential peak strain rate (D). Diastolic SR indicates diastolic strain rate; OS (%), % change in oxygenation‐sensitive signal intensity.
Figure 2
Figure 2
Exemplary patient with systolic dysfunction. Findings in an 80‐year‐old male patient with serial left anterior descending artery stenoses (C, maximal degree: 63% diameter stenosis). This patient had a previous percutaneous coronary intervention of serial right coronary artery stenoses following presentation with typical stable angina and inconclusive ergometry. In this patient, left ventricular ejection fraction dropped from 64% to 57% and cardiac index from 2.77 to 2.37 L/min/m2 after breathing oxygen, respectively. The T1 mapping image (A, top) shows myocardial injury in the septum and inferior wall, which is colocalized with both the oxygenation deficit (A, bottom) and circumferential strain (PSC) abnormalities induced with hyperoxia. At rest, the septum exhibits subnormal peak circumferential strain at end‐systole (B), which is exacerbated further at hyperoxia (yellow region). The graph shows that peak circumferential strain in poststenotic segments is attenuated across the entire cardiac cycle at hyperoxia (green) in comparison with normoxemia at room air (black). OS (%) indicates % change in oxygenation‐sensitive signal intensity.
Figure 3
Figure 3
Association between parameters of myocardial injury and hyperoxic ventricular function. Patients with indicators of myocardial injury (T1 ≥1220 ms, purple) demonstrate reduced ejection fraction (EF) and peak strain in both circumferential (PSC) and radial (PSR) orientation, all of which significantly differ from those in patients with T1 <1220 ms (orange, P=0.017, 0.025, and 0.047, respectively). Shaded green areas represent reference ranges, with the darker shade indicating mean±1 SD of healthy control measurements at normoxemia (room air) and the lighter shade representing the ±2 SD cutoff.
Figure 4
Figure 4
Indicators of regional myocardial oxygenation discordance. The plot shows the correlation coefficient (r) with 95% CI demonstrating the association between measurements obtained at normoxemia and hyperoxia‐induced myocardial oxygenation discordance (56% of patients). Green indicates P<0.05. Increasingly positive values are considered abnormal for circumferential peak strain and systolic strain rate, as well as for radial diastolic velocity and strain rate. FT‐CMR indicates feature tracking cardiovascular magnetic resonance; LV, left ventricular.

References

    1. Moradkhan R, Sinoway LI. Revisiting the role of oxygen therapy in cardiac patients. J Am Coll Cardiol. 2010;56:1013–1016.
    1. de Jonge S, Egger M, Latif A, Loke YK, Berenholtz S, Boermeester M, Allegranzi B, Solomkin J. Effectiveness of 80% vs 30‐35% fraction of inspired oxygen in patients undergoing surgery: an updated systematic review and meta‐analysis. Br J Anaesth. 2019;122:325–334.
    1. Chu DK, Kim LH‐Y, Young PJ, Zamiri N, Almenawer SA, Jaeschke R, Szczeklik W, Schünemann HJ, Neary JD, Alhazzani W. Mortality and morbidity in acutely ill adults treated with liberal versus conservative oxygen therapy (IOTA): a systematic review and meta‐analysis. Lancet. 2018;391:1693–1705.
    1. Stub D, Smith K, Bernard S, Nehme Z, Stephenson M, Bray JE, Cameron P, Barger B, Ellims AH, Taylor AJ, Meredith IT, Kaye DM; AVOID Investigators . Air versus oxygen in ST‐segment‐elevation myocardial infarction. Circulation. 2015;131:2143–2150.
    1. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S; ESC Scientific Document Group . 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST‐segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST‐Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016;37:267–315.
    1. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli‐Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P; ESC Scientific Document Group . 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST‐segment elevation: the Task Force for the management of acute myocardial infarction in patients presenting with ST‐segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39:119–177.
    1. Wenk M, Van Aken H, Zarbock A. The new World Health Organization recommendations on perioperative administration of oxygen to prevent surgical site infections: a dangerous reductionist approach? Anesth Analg. 2017;125:682–687.
    1. McNulty PH, King N, Scott S, Hartman G, McCann J, Kozak M, Chambers CE, Demers LM, Sinoway LI. Effects of supplemental oxygen administration on coronary blood flow in patients undergoing cardiac catheterization. Am J Physiol Heart Circ Physiol. 2005;288:H1057–H1062.
    1. Smit B, Smulders YM, van der Wouden JC, Oudemans‐van Straaten HM, Spoelstra‐de Man AME. Hemodynamic effects of acute hyperoxia: systematic review and meta‐analysis. Crit Care. 2018;22:45.
    1. Guensch DP, Fischer K, Shie N, Lebel J, Friedrich MG. Hyperoxia exacerbates myocardial ischemia in the presence of acute coronary artery stenosis in swine. Circ Cardiovasc Interv. 2015;8:e002928.
    1. Fischer K, Yamaji K, Luescher S, Ueki Y, Jung B, von Tengg‐Kobligk H, Windecker S, Friedrich MG, Eberle B, Guensch DP. Feasibility of cardiovascular magnetic resonance to detect oxygenation deficits in patients with multi‐vessel coronary artery disease triggered by breathing maneuvers. J Cardiovasc Magn Reson. 2018;20:31.
    1. Fischer K, Guensch DP, Friedrich MG. Response of myocardial oxygenation to breathing manoeuvres and adenosine infusion. Eur Heart J Cardiovasc Imaging. 2015;16:395–401.
    1. Stillman AE, Oudkerk M, Bluemke DA, de Boer MJ, Bremerich J, Garcia EV, Gutberlet M, van der Harst P, Hundley WG, Jerosch‐Herold M, Kuijpers D, Kwong RY, Nagel E, Lerakis S, Oshinski J, Paul JF, Slart RHJA, Thourani V, Vliegenthart R, Wintersperger BJ. Imaging the myocardial ischemic cascade. Int J Cardiovasc Imaging. 2018;34:1249–1263.
    1. Puntmann VO, Peker E, Chandrashekhar Y, Nagel E. T1 mapping in characterizing myocardial disease. Circ Res. 2016;119:277–299.
    1. Messroghli DR, Moon JC, Ferreira VM, Grosse‐Wortmann L, He T, Kellman P, Mascherbauer J, Nezafat R, Salerno M, Schelbert EB, Taylor AJ, Thompson R, Ugander M, van Heeswijk RB, Friedrich MG. Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson. 2017;19:75.
    1. Caldeira D, Vaz‐Carneiro A, Costa J. Cochrane Corner: what is the clinical impact of oxygen therapy for acute myocardial infarction? Evaluation of a Cochrane systematic review. Rev Port Cardiol. 2014;33:641–643.
    1. Khoshnood A, Akbarzadeh M, Carlsson M, Sparv D, Bhiladvala P, Mokhtari A, Erlinge D, Ekelund U. Effect of oxygen therapy on chest pain in patients with ST elevation myocardial infarction: results from the randomized SOCCER trial. Scand Cardiovasc J. 2018;52:69–73.
    1. Abuzaid A, Fabrizio C, Felpel K, Al Ashry HS, Ranjan P, Elbadawi A, Mohamed AH, Barssoum K, Elgendy IY. Oxygen therapy in patients with acute myocardial infarction: a systemic review and meta‐analysis. Am J Med. 2018;131:693–701.
    1. Sepehrvand N, James SK, Stub D, Khoshnood A, Ezekowitz JA, Hofmann R. Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta‐analysis of randomised clinical trials. Heart. 2018;104:1691–1698.
    1. Andell P, James S, Östlund O, Yndigegn T, Sparv D, Pernow J, Jernberg T, Lindahl B, Herlitz J, Erlinge D, Hofmann R. Oxygen therapy in suspected acute myocardial infarction and concurrent normoxemic chronic obstructive pulmonary disease: a prespecified subgroup analysis from the DETO2X‐AMI trial. Eur Heart J Acute Cardiovasc Care. 2019. DOI: 10.1177/2048872619848978. [Epub ahead of print].
    1. Sparv D, Hofmann R, Gunnarsson A, James S, Hedberg C, Lauermann J, Torild P, Omerovic E, Bergström K, Haugen E, Bergström C, Linder R, Borg P, Haaga U, Olsson A, Böving E, Östlund O, Rylance R, Witt N, Erlinge D; DETO2X‐SWEDEHEART Investigators . The analgesic effect of oxygen in suspected acute myocardial infarction: a substudy of the DETO2X‐AMI trial. JACC Cardiovasc Interv. 2018;11:1590–1597.
    1. Kristensen SD, Knuuti J, Saraste A, Anker S, Bøtker HE, De Hert S, Ford I, Gonzalez Juanatey JR, Gorenek B, Heyndrickx GR, Hoeft A, Huber K, Iung B, Kjeldsen KP, Longrois D, Luescher TF, Pierard L, Pocock S, Price S, Roffi M, Sirnes PA, Uva MS, Voudris V, Funck‐Brentano C; Authors/Task Force Members . 2014 ESC/ESA guidelines on non‐cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non‐cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol. 2014;31:517–573.
    1. Vascular Events In Noncardiac Surgery Patients Cohort Evaluation (VISION) Study Investigators , Devereaux PJ, Chan MTV, Alonso‐Coello P, Walsh M, Berwanger O, Villar JC, Wang CY, Garutti RI, Jacka MJ, Sigamani A, Srinathan S, Biccard BM, Chow CK, Abraham V, Tiboni M, Pettit S, Szczeklik W, Lurati Buse G, Botto F, Guyatt G, Heels‐Ansdell D, Sessler DI, Thorlund K, Garg AX, Mrkobrada M, Thomas S, Rodseth RN, Pearse RM, Thabane L, McQueen MJ, VanHelder T, Bhandari M, Bosch J, Kurz A, Polanczyk C, Malaga G, Nagele P, Le Manach Y, Leuwer M, Yusuf S. Association between postoperative troponin levels and 30‐day mortality among patients undergoing noncardiac surgery. JAMA. 2012;307:2295–2304.
    1. Writing Committee for the VISION Study Investigators , Devereaux PJ, Biccard BM, Sigamani A, Xavier D, Chan MTV, Srinathan SK, Walsh M, Abraham V, Pearse R, Wang CY, Sessler DI, Kurz A, Szczeklik W, Berwanger O, Villar JC, Malaga G, Garg AX, Chow CK, Ackland G, Patel A, Borges FK, Belley‐Cote EP, Duceppe E, Spence J, Tandon V, Williams C, Sapsford RJ, Polanczyk CA, Tiboni M, Alonso‐Coello P, Faruqui A, Heels‐Ansdell D, Lamy A, Whitlock R, LeManach Y, Roshanov PS, McGillion M, Kavsak P, McQueen MJ, Thabane L, Rodseth RN, Buse GAL, Bhandari M, Garutti I, Jacka MJ, Schünemann HJ, Cortes OL, Coriat P, Dvirnik N, Botto F, Pettit S, Jaffe AS, Guyatt GH. Association of postoperative high‐sensitivity troponin levels with myocardial injury and 30‐day mortality among patients undergoing noncardiac surgery. JAMA. 2017;317:1642–1651.
    1. Lurati Buse GAL, Schumacher P, Seeberger E, Studer W, Schuman RM, Fassl J, Kasper J, Filipovic M, Bolliger D, Seeberger MD. Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery. Circulation. 2012;126:2696–2704.
    1. Landoni G, Lomivorotov VV, Nigro Neto C, Monaco F, Pasyuga VV, Bradic N, Lembo R, Gazivoda G, Likhvantsev VV, Lei C, Lozovskiy A, Di Tomasso N, Bukamal NAR, Silva FS, Bautin AE, Ma J, Crivellari M, Farag AMGA, Uvaliev NS, Carollo C, Pieri M, Kunstýř J, Wang CY, Belletti A, Hajjar LA, Grigoryev EV, Agrò FE, Riha H, El‐Tahan MR, Scandroglio AM, Elnakera AM, Baiocchi M, Navalesi P, Shmyrev VA, Severi L, Hegazy MA, Crescenzi G, Ponomarev DN, Brazzi L, Arnoni R, Tarasov DG, Jovic M, Calabrò MG, Bove T, Bellomo R, Zangrillo A. Volatile anesthetics versus total intravenous anesthesia for cardiac surgery. N Engl J Med. 2019;380:1214–1225.
    1. Meyhoff CS, Jorgensen LN, Wetterslev J, Christensen KB, Rasmussen LS; PROXI Trial Group . Increased long‐term mortality after a high perioperative inspiratory oxygen fraction during abdominal surgery: follow‐up of a randomized clinical trial. Anesth Analg. 2012;115:849–854.
    1. Fonnes S, Gögenur I, Søndergaard ES, Siersma VD, Jorgensen LN, Wetterslev J, Meyhoff CS. Perioperative hyperoxia—long‐term impact on cardiovascular complications after abdominal surgery, a post hoc analysis of the PROXI trial. Int J Cardiol. 2016;215:238–243.
    1. Roubille F, Fischer K, Guensch DP, Tardif JC, Friedrich MG. Impact of hyperventilation and apnea on myocardial oxygenation in patients with obstructive sleep apnea—an oxygenation‐sensitive CMR study. J Cardiol. 2017;69:489–494.

Source: PubMed

3
Iratkozz fel